Torrent Pharmaceuticals has successfully raised ₹12,500 crore via debentures, a strategic move to finance its takeover of JB Chemicals & Pharmaceuticals. By issuing commercial papers and non-convertible debentures with varying maturities, Torrent attracted investments from mutual funds, insurance firms, and pension funds. This financing decision underscores Torrent’s ambition to enhance its market presence and broaden its therapeutic offerings.
Geopolitics, crude risk and the IT conundrum: Sridhar Sivaram on why investors may need to stay selective
Geopolitical tensions in West Asia are creating market uncertainty, impacting energy supplies and capital flows. While Indian equities have shown resilience, prolonged conflict could significantly